Insulin-induced vasodilatation: physiology or pharmacology? - PubMed (original) (raw)
Review
Insulin-induced vasodilatation: physiology or pharmacology?
H Yki-Järvinen et al. Diabetologia. 1998 Apr.
No abstract available
Comment in
- Insulin-mediated vasodilation: why one's physiology could be the other's pharmacology.
Steinberg HO, Baron AD. Steinberg HO, et al. Diabetologia. 1999 Apr;42(4):493-5. doi: 10.1007/s001250051184. Diabetologia. 1999. PMID: 10230655 No abstract available. - Insulin-mediated vasodilation and forearm plethysmography: physiology not pharmacology.
Petrie JR, Cleland SJ, Ueda S, Elliott HL, Connell JM. Petrie JR, et al. Diabetologia. 1999 Nov;42(11):1376. doi: 10.1007/s001250051453. Diabetologia. 1999. PMID: 10550424 No abstract available.
Similar articles
- Vascular defects in the aetiology of peripheral insulin resistance in diabetes. A critical review of hypotheses and facts.
Wiernsperger N. Wiernsperger N. Diabetes Metab Rev. 1994 Oct;10(3):287-307. doi: 10.1002/dmr.5610100305. Diabetes Metab Rev. 1994. PMID: 7835173 Review. No abstract available. - Insulin-mediated blood flow and glucose uptake.
Floras JS, Meneilly G. Floras JS, et al. Can J Cardiol. 2001 May;17 Suppl A:7A-10A. Can J Cardiol. 2001. PMID: 11381287 - Insulin resistance and vasodilation in essential hypertension. Studies with adenosine.
Natali A, Bonadonna R, Santoro D, Galvan AQ, Baldi S, Frascerra S, Palombo C, Ghione S, Ferrannini E. Natali A, et al. J Clin Invest. 1994 Oct;94(4):1570-6. doi: 10.1172/JCI117498. J Clin Invest. 1994. PMID: 7929833 Free PMC article. Clinical Trial. - Intact insulin stimulation of skeletal muscle blood flow, its heterogeneity and redistribution, but not of glucose uptake in non-insulin-dependent diabetes mellitus.
Utriainen T, Nuutila P, Takala T, Vicini P, Ruotsalainen U, Rönnemaa T, Tolvanen T, Raitakari M, Haaparanta M, Kirvelä O, Cobelli C, Yki-Järvinen H. Utriainen T, et al. J Clin Invest. 1997 Aug 15;100(4):777-85. doi: 10.1172/JCI119591. J Clin Invest. 1997. PMID: 9259575 Free PMC article. - [Diabetes mellitus and sports. Why the athletic diabetic patient uses less insulin].
Neye H. Neye H. Med Monatsschr Pharm. 1994 Sep;17(9):273-6. Med Monatsschr Pharm. 1994. PMID: 7968779 Review. German. No abstract available.
Cited by
- Early microvascular recruitment modulates subsequent insulin-mediated skeletal muscle glucose metabolism during lipid infusion.
Eggleston EM, Jahn LA, Barrett EJ. Eggleston EM, et al. Diabetes Care. 2013 Jan;36(1):104-10. doi: 10.2337/dc11-2399. Epub 2012 Sep 6. Diabetes Care. 2013. PMID: 22961574 Free PMC article. Clinical Trial. - Schizophrenia patients with a metabolically abnormal obese phenotype have milder negative symptoms.
Wang J, Zhang Y, Liu Z, Yang Y, Zhong Y, Ning X, Zhang Y, Zhao T, Xia L, Geng F, Tao R, Fan M, Ren Z, Liu H. Wang J, et al. BMC Psychiatry. 2020 Aug 18;20(1):410. doi: 10.1186/s12888-020-02809-4. BMC Psychiatry. 2020. PMID: 32811450 Free PMC article. - Insulin signalling and resistance in patients with chronic heart failure.
Kemppainen J, Tsuchida H, Stolen K, Karlsson H, Björnholm M, Heinonen OJ, Nuutila P, Krook A, Knuuti J, Zierath JR. Kemppainen J, et al. J Physiol. 2003 Jul 1;550(Pt 1):305-15. doi: 10.1113/jphysiol.2003.042648. Epub 2003 May 9. J Physiol. 2003. PMID: 12740426 Free PMC article. - Unchanged asymmetric dimethylarginine levels in non-diabetic, premenopausal obese women who have common risk factors for cardiovascular disease.
Cetinalp-Demircan P, Can A, Bekpinar S, Unlucerci Y, Orhan Y. Cetinalp-Demircan P, et al. Endocrine. 2007 Apr;31(2):100-4. doi: 10.1007/s12020-007-0005-z. Endocrine. 2007. PMID: 17873318 - Molecular and clinical aspects of endothelial dysfunction in diabetes.
Nacci C, Tarquinio M, Montagnani M. Nacci C, et al. Intern Emerg Med. 2009 Apr;4(2):107-16. doi: 10.1007/s11739-009-0234-7. Epub 2009 Mar 10. Intern Emerg Med. 2009. PMID: 19280353
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical